RxDoctor Payments Data

Fatmeh Barada

Family · Dearborn, MINPI 1013592765

Payments from drug & device makers

$1,217in general payments, 2019–2025

Across 64 payments — averaging $19.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$206
  • Merck$147
  • GSK$131
  • Amgen$91
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$87
  • Lilly USA, LLC$83
  • plus $471 from 17 others

What the payments were for

  • Food & beverage$1,217100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,217 in reported general payments places this provider in the 70th percentile of 3,657 family providers in Michigan.

See all family providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin42$29,242
TrulicityDulaglutide22$23,255
JanuviaSitagliptin Phosphate29$22,562
LinzessLinaclotide33$19,651
OzempicSemaglutide21$19,482
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$18,578
TrintellixVortioxetine Hydrobromide29$15,544
EliquisApixaban23$14,136
FarxigaDapagliflozin Propanediol16$11,284
MyrbetriqMirabegron12$7,137
Breo ElliptaFluticasone/Vilanterol17$6,588
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog14$5,337
Incruse ElliptaUmeclidinium Bromide13$4,192
Ventolin HfaAlbuterol Sulfate65$3,667
Fluticasone-SalmeterolFluticasone Propion/Salmeterol18$2,916

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta$131$29,35859 claims
Boehringer IngelheimJardiance$61$29,24242 claims
Lilly USA, LLCTrulicity$83$23,25522 claims
MerckJanuvia$147$22,56229 claims
AbbVieLinzess$206$19,65133 claims
AstraZenecaFarxiga$13$11,28416 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,657 family providers in Michigan.

Other family in Dearborn

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →